Company Overview of AmnioLife Corporation

Company Overview

AmnioLife Corporation, a biotechnology company, develops and commercializes a biologic suite of products to address underserved and unmet market needs with product applications across various collagen repair markets. It offers Xceed, a non-structural acellular purified amniotic fluid for various applications and treatments, including tendonitis, gingival defects, reduction of scarring, chronic wound covering, soft tissue or bone trauma, and treatment of localized inflammation; and ProLifix, an extracellular matrix solution for dermal burns, adhesion barrier, chronic wound allograft, reduce scar tissue formation, nerve bundle and peripheral wrap, and periodontal guided tissue regeneration app...

AmnioLife Corporation, a biotechnology company, develops and commercializes a biologic suite of products to address underserved and unmet market needs with product applications across various collagen repair markets. It offers Xceed, a non-structural acellular purified amniotic fluid for various applications and treatments, including tendonitis, gingival defects, reduction of scarring, chronic wound covering, soft tissue or bone trauma, and treatment of localized inflammation; and ProLifix, an extracellular matrix solution for dermal burns, adhesion barrier, chronic wound allograft, reduce scar tissue formation, nerve bundle and peripheral wrap, and periodontal guided tissue regeneration applications. The company also provides contract manufacturing and private branding services. It serves medical professionals. AmnioLife Corporation was founded in 2013 and is based in Gainesville, Florida.

Key Executives for AmnioLife Corporation

Similar Private Companies By Industry

Recent Private Companies Transactions